News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VasoStitch, Inc. 's "Enabling TAVI” Platform for Nonsurgical Deployment of Transcatheter Therapies is Selected for Presentation at EuroPCR 2012


4/17/2012 10:51:46 AM

DANVILLE, Calif.--(BUSINESS WIRE)--VasoStitch, a start-up medical technology company, announced today that its technology will be featured at “EuroPCR,” Europe’s most important interventional cardiology-focused annual scientific meeting of the year, on Thursday, May 17th, in Paris. VasoStitch is developing a percutaneous access-and-closure system for the nonsurgical deployment of large-diameter transcatheter therapeutic devices, such as Transcatheter Aortic Valve Implants (TAVI) and Endovascular Aneurysm Repair (EVAR) devices. The VasoStitch system is designed to reduce procedural complexity and eliminate the need for an “open” surgical procedure.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES